In The Spotlight
DDNews Cancer Research Exclusive
 
 
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
 
(Photo credit: University of Toronto)
 
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
 
 
NEWS
Deal focused on development of therapies in autoimmune disease and immuno-oncology
 
GT Biopharma encouraged by clinical potential of triple-threat TriKE cells in cancer
 
Investigational therapeutic for Colorectal Cancer shows promise in preclinical study
 
Roswell Park researchers publish two studies on progress against the disease
 
Trial indicates that the process shows benefit for gliobastoma patients
 
Treading the edge between autoimmunity and oncology
 
Glioblastoma remains a difficult cancer to treat, but the brain malignancy is seeing increasing attention in R&D
 
TRACON announces results from ongoing Phase 1b/2 trial in hepatocellular carcinoma
 
  
FEATURES
 

Columbia Business School report examines how cancer drugs have impacted mortality for patients
 
OPINION
CAR-T Next Generation Immunotherapy: Better Targeting, New Approaches
by Dr. Eyal Talor, CEL-SCI
A look at what to expect from the second generation of cancer immunotherapies, after the progress--and pitfalls--of CAR-T cell therapies

Guest Commentary: Planning successful oncology trials amid a rapidly shifting treatment landscape
by JK Bryan & A Zupnick, Novella
When it comes to oncology clinical trials, drug developers need to stay abreast of the rapidly evolving and competitive landscape while also remaining flexible and innovative in responding to these changes

Enhancing Immuno-Oncology with RNA Interference
by Dr. Alexey Eliseev, RXi
The “War on Cancer” declared by the National Cancer Act of 1971 proceeded through a series of evolutionary developments in chemotherapy, radiation treatments and targeted therapies, but until recently was only marginally successful in extending the lives of late-stage cancer patients. A major breakthrough has been achieved over the last decade with the development of immunotherapeutic treatments that empower a patient’s own immune cells to destroy tumors

 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.